The LEGOCHIP Consortium is composed by an interdisciplinary team of European researchers with well-recognized scientific excellence in their respective fields and successful collaborative history. This project will merge pioneering know-how and experience in graphene nanotechnology, nanophotonics sensing, surface chemistry, biological analysis, and clinical diagnostics to accomplish the urgent demands of the European Union regarding healthcare promotion and technology innovation. The uniqueness and ground-breaking nature of LEGOCHIP is a direct result of the Consortium collaboration and partnering.
The research Consortium consists of 4 partners:
- Catalan Institute of Nanoscience and Nanotechnology (ICN2)
- University of Santiago de Compostela (USC)
- University of Manchester
- Università di Bologna
Catalan Institute of Nanoscience and Nanotechnology (COORDINATOR)
Web: icn2.cat [+]
The Catalan Institute of Nanoscience and Nanotechnology (ICN2), member of the Barcelona Institute of Science and Technology (BIST), carries out research into the behaviour of materials at nanoscale. The institute creates basic knowledge and develops devices in a wide range of fields, from life sciences (medicine, health and the environment) to energy and information and communications technologies. This cutting-edge research has enormous potential to change everyday life.The trustees of the ICN2 include the Generalitat of Catalunya, the Spanish National Research Council (Consejo Superior de Investigaciones Científicas, CSIC) and the Universitat Autònoma de Barcelona (UAB). The institute was recognised as a Severo Ochoa Centre of Excellence for the development of the “Nanodevices for social challenges” programme (2014-2018) and has been recognised for a new four year period.
Two ICN2 research units participate in LEGOCHIP:
- Atomic Manipulation and Spectroscopy group [+]
- Nanobiosensors and Bioanalytical Applications Group [+]
University of Santiago de Compostela
USC is a public university established in 1495. USC hosts ~28000 students, among which ~3000 are PhD students. USC has been recognized as International Campus of Excellence, a Spanish strategic program specialized in life sciences and technologies. CiQUS (Center for Research in Biological Chemistry and Molecular Materials) develops transdisciplinary strategies to undertake major challenges in Molecular Sciences. In 2016, CiQUS obtained the best evaluation in the accreditation of Excellence University Research Centers from the Galician Government. CiQUS’ research activity focused on three major areas: Functional Materials, Biological and Medicinal Chemistry and Synthetic Technologies.
More info about the participating group [+]
University of Manchester
Web: manchester.ac.uk [+]
Since the isolation of graphene at University of Manchester in the preceding decade the scientific community has been working towards the development of new applications of this 2D material in a wide variety of fields. UMan supports a critical mass of over 60 academic staff, post-doctoral researchers and postgraduate students involved in various aspects of graphene research and other 2D materials that creates a good atmosphere for strong synergy and collaboration.
Università di Bologna
Università di Bologna is the oldest university in the Western world. As a comprehensive research university, Università di Bologna invests in the multidisciplinary cross-cultural approach, leading and participating in European research and academic cooperation projects, and forming knowledge alliances with industry and public/private organizations. With regards to Innovation, Università di Bologna filed 86 new patent applications in 2017, thereby giving rise to an active patent portfolio of over 370 patents related to more than 140 inventions. With regard to the capability to attract grant funding for research and innovation, Università di Bologna is very active both at National and European level in all the research areas. Local healthcare facilities, including Policlinico S.Orsola-Malpighi, are managed in collaboration with Università di Bologna. Therefore, the collaboration between clinical units and basic or translational research groups is guaranteed.